Table 1.
Overall in-vitro susceptibility of the main Gram-negative rods to commonly used per-oral antibiotics (N/D - not defined susceptibility according to used EUCAST guidelines)
| Fosfomycin | Nitrofurantoin | Ampicillin | Ampicillin-sulbactam | Cefuroxime | Ciprofloxacin | Co-trimoxazole | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S% | R% | S% | R% | S% | R% | S% | R% | S% | R% | S% | R% | S% | R% | |
| E. coli (n = 1703) | 97.0 | 2.2 | 96.6 | 3.4 | 46.3 | 53.7 | 76.3 | 23.7 | 90.5 | 9.5 | 75.8 | 24.0 | 67.8 | 31.8 |
| K. pneumoniae (n = 643) | 80.4 | 10.0 | 64.9 | 35.1 | 0.0 | 100.0 | 43.5 | 56.5 | 51.9 | 48.1 | 52.4 | 47.0 | 49.4 | 50.3 |
| Proteus sp.(n = 392) | 78.3 | 16.6 | N/D | N/D | 38.8 | 61.2 | 84.5 | 15.5 | 81.6 | 18.4 | 68.9 | 28.8 | 51.3 | 47.7 |
| Enterobacter sp.(n = 261) | 82.8 | 11.1 | N/D | N/D | 0.0 | 100.0 | 0.0 | 100.0 | N/D | N/D | 77.2 | 19.7 | 71.4 | 27.8 |
| Citrobacter sp. (n = 97) | 100.0 | 0.0 | N/D | N/D | 0.0 | 100.0 | 40.2 | 59.8 | N/D | N/D | 90.7 | 9.3 | 76.3 | 23.7 |
| M. morganii (n = 68) | 16.2 | 75.0 | N/D | N/D | 0.0 | 100.0 | 0.0 | 100.0 | N/D | N/D | 72.1 | 22.0 | 61.8 | 33.8 |
| Providencia sp. (n = 34) | 44.1 | 50.0 | N/D | N/D | 0.0 | 100.0 | 0.0 | 100.0 | N/D | N/D | 61.8 | 38.2 | 73.5 | 26.5 |
E. coli Escherichia coli, K. pneumoniae Klebsiella pneumoniae, Proteus sp. Proteus species, Enterobacter sp. Enterobacter species, Citrobacter sp. Citrobacter species, M. morganii Morganella morganii, Providencia sp. Providencia species